Literature DB >> 7877128

Psychotherapy in functional dyspepsia.

T T Haug1, I Wilhelmsen, S Svebak, A Berstad, H Ursin.   

Abstract

Patients with functional dyspepsia were assigned at random to cognitive psychotherapy (10 sessions of 50 min duration, n = 50) or to a control group (no treatment, n = 50). Before treatment all patients were assessed on psychological, somatic and lifestyle factors. If allocated to the therapy group all patients were also asked to define the main problems they wanted to discuss in therapy ('target complaints'). The patients were evaluated at the end of therapy (after 4 months) and at 1 yr follow-up. Outcome measures were dyspeptic symptoms, scores on 'target complaints' and psychological parameters. Both groups showed improvement in dyspeptic and psychological parameters after 1 yr. The improvement in the control group was attributed to a non- specific effect of increased interest and attention. The therapy group showed greater reduction than the control group on dyspeptic symptoms [days of epigastric pain (p = 0.050), nausea (p = 0.024), heartburn (p = 0.021), diarrhoea (p = 0.002) and constipation (p = 0.047)]; and on scores on 'target complaints' (p = 0.001).

Entities:  

Mesh:

Year:  1994        PMID: 7877128     DOI: 10.1016/0022-3999(94)90026-4

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  23 in total

Review 1.  The role of psychosocial factors in gastrointestinal disorders.

Authors:  I Wilhelmsen
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

Review 3.  Review article: current treatment options and management of functional dyspepsia.

Authors:  B E Lacy; N J Talley; G R Locke; E P Bouras; J K DiBaise; H B El-Serag; B P Abraham; C W Howden; P Moayyedi; C Prather
Journal:  Aliment Pharmacol Ther       Date:  2012-05-16       Impact factor: 8.171

4.  Many patients continue using proton pump inhibitors after negative results from tests for reflux disease.

Authors:  Andrew J Gawron; Jami Rothe; Angela J Fought; Anita Fareeduddin; Erin Toto; Lubomyr Boris; Peter J Kahrilas; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-22       Impact factor: 11.382

5.  Evidence-based clinical practice guidelines for functional dyspepsia.

Authors:  Hiroto Miwa; Motoyasu Kusano; Tomiyasu Arisawa; Tadayuki Oshima; Mototsugu Kato; Takashi Joh; Hidekazu Suzuki; Kazunari Tominaga; Koji Nakada; Akihito Nagahara; Seiji Futagami; Noriaki Manabe; Akio Inui; Ken Haruma; Kazuhide Higuchi; Koji Yakabi; Michio Hongo; Naomi Uemura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-14       Impact factor: 7.527

6.  Treatment of functional dyspepsia.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

7.  Functional Dyspepsia: A New Rome III Paradigm.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

Review 8.  Current management strategies and emerging treatments for functional dyspepsia.

Authors:  Michael Camilleri; Vincenzo Stanghellini
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-05       Impact factor: 46.802

9.  Treatment of Functional Dyspepsia.

Authors:  Christine Feinle-Bisset; Jane M. Andrews
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

Review 10.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.